Q3 2023 EPS Estimates for Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Increased by Wedbush kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Wedbush reiterated their outperform rating on shares of Theseus Pharmaceuticals (NASDAQ:THRX – Free Report) in a research report sent to investors on Thursday, RTT News reports. The brokerage currently has a $7.00 target price on the stock. Wedbush also issued estimates for Theseus Pharmaceuticals’ Q1 2024 earnings at ($0.33) EPS, Q2 2024 earnings at ($0.35) […]
Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0 33) Per Share modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Opaleye Management Inc. grew its stake in shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Rating) by 142.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 535,000 shares of the company’s stock after buying an additional 314,350 shares during the period. Opaleye Management Inc.’s holdings in Theseus […]